Equity (Details Textual) (USD $)
|
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Feb. 28, 2011
|
|
Equity (Textual) [Abstract] | |||||
Equity increase during the period | $ 944,400,000 | ||||
Net income attributable to Biogen Idec Inc | 714,506,000 | 490,670,000 | 1,194,462,000 | 917,419,000 | |
Adjustments to additional paid in capital, share-based compensation and exercise of stock options | 82,400,000 | ||||
Common stock shares authorized for repurchase | 3,000,000 | 3,000,000 | 20,000,000.0 | ||
Repurchase of common stock, shares | 1,200,000 | 300,000 | |||
Purchase of treasury stock, value | $ 336,905,000 | $ 41,023,000 |
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Changes in additional paid in capital related to exercise of share-based payments awards (such as stock options) and the amount of recognized equity-based compensation during the period (such as nonvested shares). No definition available.
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow to reacquire common stock during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The increase (decrease) in stockholders' equity during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan. No definition available.
|
X | ||||||||||
- Definition
Number of shares that have been repurchased during the period and are being held in treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|